Skip to content
Parakho

Acutaas Chemicals Ltd

NSE ACUTAASBSE 543349acutaas.com

Q1 FY27, unaudited

Revenue
₹329.67 Cr
Profit after tax
₹74.99 Cr

As filed with the exchange, consolidated basis.

Statement of profit and loss

Figures in ₹ crore, reproduced from the results data files the company filed with NSE under Regulation 33 of the SEBI (LODR) Regulations. Nothing is restated, adjusted or estimated.

Statement of profit and loss, consolidated basis
₹ croreQ1 FY27vs a year agoFY26
Revenue from operations329.67+59.08%1,339.37
Other income1.80−88.70%41.59
Total income331.48+48.53%1,380.95
Employee benefit expense39.57+57.81%117.57
Finance costs1.14+78.70%3.27
Depreciation & amortisation9.82+20.79%35.99
Total expenses227.57+37.84%898.23
Profit before tax103.91+78.92%482.73
Tax expense28.92+105.60%126.36
Profit after tax74.99+70.40%356.37
Total comprehensive income72.83+65.62%353.14
Earnings per share
Earnings per share, basic₹9.07₹43.51
Earnings per share, diluted₹9.04₹43.37

Q1 FY27 — unaudited, from the company’s filing with NSE. Source

Q1 FY26, the year-ago base — unaudited, from the company’s filing with NSE. Source

FY26 — unaudited, from the company’s filing with NSE. Source

Q1 FY27 results for every company Parakho holds

Earnings call

Q1 FY27

Acutaas Chemicals reported Q1 FY27 revenue of INR329.7 crores, up 59.1% year-on-year, with EBITDA margin expanding to 34.3% and PAT of INR74.9 crores. Management attributed the growth to strong performance in the Advanced Pharmaceutical Intermediates segment, particularly CDMO, while the Specialty Chemicals segment declined due to the planned phase-out of commodity chemicals. The company also reported completion of trial runs at its new battery chemicals plant and commencement of commercial supply, along with progress on the Indichem semiconductor chemicals plant in Korea.

Generated by AI from the filed transcript; every statement on the full page carries its verbatim quote.

Read the full summary

Earlier calls: Q4 FY26 · All quarters

Filings

12 shown · 53 published by the exchange

BSE corporate announcements, classified by Parakho. The exchange’s own category is kept alongside our classification so a reclassification never rewrites history.

Industry

Healthcare › Pharmaceuticals

Classification as published by BSE.

Companies also in Pharmaceuticals, in alphabetical order

All 196 companies in Pharmaceuticals

Page generated from filings held to 06 Oct 2026.